Issue 2/2018
Migraine Therapeutics: Current Practice, Recent Advances and Future Directions
Content (24 Articles)
Migraine Treatment: Current Acute Medications and Their Potential Mechanisms of Action
Jonathan Jia Yuan Ong, Milena De Felice
Targeted CGRP Small Molecule Antagonists for Acute Migraine Therapy
Philip R. Holland, Peter J. Goadsby
Current Prophylactic Medications for Migraine and Their Potential Mechanisms of Action
Till Sprenger, M. Viana, C. Tassorelli
The Biology of Monoclonal Antibodies: Focus on Calcitonin Gene-Related Peptide for Prophylactic Migraine Therapy
Bianca Raffaelli, Uwe Reuter
Therapeutic Approaches for the Management of Trigeminal Autonomic Cephalalgias
Diana Y. Wei, Rigmor H. Jensen
Targeted Pituitary Adenylate Cyclase-Activating Peptide Therapies for Migraine
Anne Luise Haulund Vollesen, Faisal Mohammad Amin, Messoud Ashina
Targeted Orexin and Hypothalamic Neuropeptides for Migraine
Lauren C. Strother, Anan Srikiatkhachorn, Weera Supronsinchai
Targeted Nitric Oxide Synthase Inhibitors for Migraine
Amynah A. Pradhan, Zachariah Bertels, Simon Akerman
Targeted Acid-Sensing Ion Channel Therapies for Migraine
Nazia Karsan, Eric B. Gonzales, Gregory Dussor
Anti-herpetic Medications and Reduced Risk of Dementia in Patients with Herpes Simplex Virus Infections—a Nationwide, Population-Based Cohort Study in Taiwan
Nian-Sheng Tzeng, Chi-Hsiang Chung, Fu-Huang Lin, Chien-Ping Chiang, Chin-Bin Yeh, San-Yuan Huang, Ru-Band Lu, Hsin-An Chang, Yu-Chen Kao, Hui-Wen Yeh, Wei-Shan Chiang, Yu-Ching Chou, Chang-Huei Tsao, Yung-Fu Wu, Wu-Chien Chien
Safety and Efficacy of Nanocurcumin as Add-On Therapy to Riluzole in Patients With Amyotrophic Lateral Sclerosis: A Pilot Randomized Clinical Trial
Mona Ahmadi, Elmira Agah, Shahriar Nafissi, Mahmoud Reza Jaafari, Mohammad Hossein Harirchian, Payam Sarraf, Sara Faghihi-Kashani, Seyed Jalal Hosseini, Abdolreza Ghoreishi, Vajiheh Aghamollaii, Mostafa Hosseini, Abbas Tafakhori
Nerve Ultrasound Predicts Treatment Response in Chronic Inflammatory Demyelinating Polyradiculoneuropathy—a Prospective Follow-Up
Florian Härtig, Marlene Ross, Nele Maria Dammeier, Nadin Fedtke, Bianka Heiling, Hubertus Axer, Bernhard F. Décard, Eva Auffenberg, Marilin Koch, Tim W. Rattay, Markus Krumbholz, Antje Bornemann, Holger Lerche, Natalie Winter, Alexander Grimm
Pilot Single-Blind Trial of AbobotulinumtoxinA in Oromandibular Dystonia
Laura M. Scorr, Michael R. Silver, John Hanfelt, Elaine Sperin, Alan Freeman, H. A. Jinnah, Stewart A. Factor
Cannabinoid CB1 and CB2 Receptors, and Monoacylglycerol Lipase Gene Expression Alterations in the Basal Ganglia of Patients with Parkinson’s Disease
Francisco Navarrete, M. Salud García-Gutiérrez, Auxiliadora Aracil-Fernández, José L. Lanciego, Jorge Manzanares
Intrinsic Inflammation Is a Potential Anti-Epileptogenic Target in the Organotypic Hippocampal Slice Model
Seon-Ah Chong, Silvia Balosso, Catherine Vandenplas, Gregory Szczesny, Etienne Hanon, Kasper Claes, Xavier Van Damme, Bénédicte Danis, Jonathan Van Eyll, Christian Wolff, Annamaria Vezzani, Rafal M. Kaminski, Isabelle Niespodziany
Alleviation of Trigeminal Nociception Using p75 Neurotrophin Receptor Targeted Lentiviral Interference Therapy
Valerie B. O’Leary, Marie O’Connell, Inga Antyborzec, Vasilis Ntziachristos, J. Oliver Dolly, Saak V. Ovsepian
Brain Renin–Angiotensin System Blockade Attenuates Methamphetamine-Induced Hyperlocomotion and Neurotoxicity
Linhong Jiang, Ruiming Zhu, Qian Bu, Yan Li, Xue Shao, Hui Gu, Jueying Kong, Li Luo, Hailei Long, Wei Guo, Jingwei Tian, Yinglan Zhao, Xiaobo Cen
Correction to: Neuroimmune Response in Ischemic Preconditioning
Ashley McDonough, Jonathan R. Weinstein
Correction to: Migraine Treatment: Current Acute Medications and Their Potential Mechanisms of Action
Jonathan Jia Yuan Ong, Milena De Felice